Enteroviruses commonly infect the gastrointestinal tract, and replication of enteroviruses has been well documented in the Peyer patches of the small bowel. Chronic enterovirus infection has been found in the stomach and terminal ileum of patients with myalgic encephalomyelitis/chronic fatigue syndrome. The authors report the unexpected finding of enterovirus VP1 protein, by immunoperoxidase staining, in carcinoid tumours found in one patient with myalgic encephalomyelitis/chronic fatigue syndrome and another patient with chronic lower quadrant abdominal pain, and suggest a possible association between enteroviruses and tumorigenesis.
Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury
Authors: Kaiser PR et al Summary: This pilot study evaluated the effects of modafanil treatment in patients with excessive daytime sleepiness (EDS) and fatigue after traumatic brain injury (TBI). 20 patients who had fatigue and/or EDS after TBI were randomised to receive placebo or modafinil 100-200mg each morning for 6 weeks in a doubleblind manner. Sleepiness and fatigue were assessed at baseline and 6 weeks. EDS (assessed using the Epworth Sleepiness Scale) and the ability to stay awake (assessed using the Maintenance of Wakefulness Test) improved significantly in modafanil recipients compared with placebo recipients after 6 weeks. Neither modafanil nor placebo had any effects on post-traumatic fatigue. In conclusion, modafinil was effective and well tolerated in patients with post-traumatic EDS but had no effects on fatigue. Comment: This is an only slightly satisfying study. While sleepiness is a problem for a few patients post head injury, fatigue is much more common. Along with headaches, poor concentration, irritability and dizziness, fatigue forms part of the puzzling and treatment-resistant post-concussion syndrome. While most patients improve with time, a proportion make very little progress and the symptoms remain a burden for themselves, their family and the health system. However, few studies have explored the possibility of dissociation between verbal and visuospatial memory impairments in FM. Therefore, the purpose of this study was to investigate the asymmetrical impairment of cognitive functions between verbal and visuospatial memory and between short-term and long-term memory.
Neuropsychological assessments were carried out on 23 female patients with FM and 24 healthy female controls. Verbal memory abilities were assessed using the Korean version of the Rey auditory verbal learning test (KAVLT) and digit span task, and visuospatial memory abilities were assessed using the Korean version of the Rey complex figure test (KCFT) and spatial span task.
The analysis of covariance was used to assess group differences in performance on cognitive tests after controlling for depression. The two groups did not significantly differ in terms of age, years of education, or in their estimated verbal and performance IQ, but FM patients reported more severe depressive symptoms than did controls on the Beck depression inventory.
Significant group differences were found in immediate and delayed recall on the KCFT (F (1,44) = 6.49, p = 0.014 and F (1,44) = 6.96, p = 0.011, respectively), whereas no difference was found in immediate and delayed recall on the KAVLT. In terms of short-term memory, neither the digit span task nor spatial span task showed any difference between groups, regardless of whether repetition was forward or backward.
These findings suggest that spatial memory abilities may be more impaired than verbal memory abilities in patients with FM. treatment of fibromyalgia.
A literature search was conducted and 8 studies matched criteria (7 studies of pregabalin, 1 of gabapentin). Both drugs reduced mean pain scores more than placebo at a modest rate (pregabalin, 38% to 50%; gabapentin, 51%). In a 6-month trial of pregabalin responders, 32% continued to have response at 6 months, with a mean time to loss of response of 34 days.
Compared to placebo, the drugs had similarly high rates of adverse events and withdrawals. Without a head-to-head trial it is not possible to conclude if 1 antiepileptic is more effective or harmful than the other, although limited evidence suggests potential differences.
Future studies must directly compare the drugs, include a more broadly defined population, examine long term benefits and harms, and include cointerventions. We conclude that pregabalin and gabapentin are modestly effective for the treatment of fibromyalgia but that their long-term safety and efficacy remain unknown.
Several previous studies of chronic pain patients, including FM, have shown gray matter atrophy of brain areas associated with sensory and affective pain processing. These findings, however, have not been confirmed in all FM studies.
In this study, we investigated gray matter volumes of brain areas associated with pain-related areas of FM patients identified by functional brain imaging.
Using voxel-based morphometric (VBM) analysis of magnetic resonance brain images, we compared 19 pain-related brain areas of 14 female FM patients and 11 healthy controls (NC).
We found that FM patients had significantly less gray matter volumes than NC in 3 of these brain regions, including the anterior and mid-cingulate, as well as mid-insular cortices.
Importantly, FM patients demonstrated neither global gray matter atrophy nor gray matter changes associated with depression, as shown in some studies.
Using a more stringent analysis than other VBM studies, we provide evidence for decreased gray matter volumes in a number of pain-related brain areas in FM. Although the mechanisms for these gray matter changes are presently unclear, they may contribute to some of the core features of this chronic disorder including affective disturbances and chronic widespread pain.
